Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,940 public trials 1,514 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Active, Not Recruiting

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT05445778

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Usa Mitchell Cancer Institute /ID# 269661 Mobile, Alabama, United States
  • Honorhealth Virginia G. Piper Cancer Care Network - Biltmore /ID# 269987 Phoenix, Arizona, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 269573 Irvine, California, United States
  • Moores Cancer Center at UC San Diego /ID# 269564 La Jolla, California, United States
View all 264 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

NCT06360354

Conditions
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Duarte, California, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

REACT - Resistance Exercise After Cancer Treatment

NCT07159815

Conditions
Cancer, Neoplasms
Locations
  • Innlandet Hospital Trust/ Pusterommet Gjøvik Gjøvik, Norway
  • The Hamar Training Centre Hamar, Norway
  • Aktivklinikken Lillehammer, Norway
  • Inland Norway University of Applied Sciences Lillehammer, Norway
View Trial Details
Active, Not Recruiting

A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

NCT06593522

Conditions
MTAP-deleted NSCLC, Neoplasms
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 91 locations
View Trial Details
Active, Not Recruiting

Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

NCT06333951

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Duarte, California, United States
  • Translational Research in Oncology US Inc, Trio Central Pharmacy Los Angeles, California, United States
View all 83 locations
View Trial Details

Related conditions